Integra Lifesciences's market cap is currently ―. The company's EPS TTM is $0.843; its P/E ratio is 37.73; Integra Lifesciences is scheduled to report earnings on April 25, 2024, and the estimated EPS forecast is $0.55. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 382.42M	$ 381.27M	$ 380.85M	$ 398.02M	$ 385.19M
Gross Profit	$ 218.34M	$ 207.03M	$ 232.87M	$ 250.09M	$ 236.75M
EBIT	$ 31.67M	$ 16.29M	$ 41.88M	$ 77.10M	$ 71.61M
EBITDA	$ 62.23M	$ 47.11M	$ 73.02M	$ 106.60M	$ 101.07M
Net Income Common Stockholders	$ 19.50M	$ 4.18M	$ 24.23M	$ 52.95M	$ 49.91M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 273.73M	$ 309.19M	$ 307.37M	$ 456.66M	$ 511.94M
Total Assets	$ 3.74B	$ 3.78B	$ 3.74B	$ 3.89B	$ 3.81B
Total Debt	$ 1.69B	$ 1.60B	$ 1.51B	$ 1.62B	$ 1.71B
Net Debt	$ 1.41B	$ 1.29B	$ 1.20B	$ 1.16B	$ 1.20B
Total Liabilities	$ 2.16B	$ 2.09B	$ 2.07B	$ 2.09B	$ 2.08B
Stockholders Equity	$ 1.58B	$ 1.68B	$ 1.67B	$ 1.80B	$ 1.72B
Cash Flow	-
Free Cash Flow	$ 11.49M	$ 11.35M	$ 7.75M	$ 70.88M	$ 59.16M
Operating Cash Flow	$ 24.57M	$ 26.90M	$ 21.46M	$ 85.33M	$ 68.31M
Investing Cash Flow	$ -5.50M	$ -14.17M	$ -9.01M	$ -54.82M	$ 14.80M
Financing Cash Flow	$ -49.66M	$ -10.69M	$ -162.68M	$ -97.70M	$ -7.64M

Currency in USD

Integra Lifesciences Earnings and Revenue History

Income Statement >

Integra Lifesciences Debt to Assets

Balance Sheet >

Integra Lifesciences Cash Flow

Cash Flow >

Integra Lifesciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing